Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Ratios

CapsoVision (CV) Capital Expenditures (2024 - 2025)

CapsoVision's Capital Expenditures history spans 2 years, with the latest figure at $8000.0 for Q4 2025.

On a quarterly basis, Capital Expenditures changed N/A to $8000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $24000.0, a N/A change, with the full-year FY2025 number at $90000.0, down 41.18% from a year prior.
Capital Expenditures hit $8000.0 in Q4 2025 for CapsoVision, down from $12000.0 in the prior quarter.
Over the last five years, Capital Expenditures for CV hit a ceiling of $12000.0 in Q3 2025 and a floor of $4000.0 in Q3 2024.